SCHEMBL6353290

SCHEMBL6353290

CSc1ccc2nc3c(c(C)nn3-c3ccccn3)c(Cl)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.43
ALDH1A1 P00352 7/20 0.43
HPGD P15428 6/20 0.43
MAPT P10636 6/20 0.43
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 2/20 0.43
HTT P42858 1/20 0.43
USP2 O75604 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 3/20 0.39
SPR P35270 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
PIK3CD O00329 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6340244 0.87 SPR (0.47) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6345022 0.87 MEN1 (0.48) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6342526 0.85 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6340229 0.85 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6353414 0.85 SPR (0.46) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6343061 0.84 ALDH1A1 (0.46) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6343058 0.84 ALDH1A1 (0.56) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6340112 0.82 NR3C1 (0.43) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6345276 0.82 KDM4E (0.41) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6342681 0.81 ALDH1A1 (0.42) KDM4EALDH1A1HPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 KDM4E 1741/4885ALDH1A1 1061/4885HPGD 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.